Publication:
Coordinated in vitro release of granulysin, perforin and IFN-γ in tb and HIV/TB co-infection associated with clinical outcomes before and after anti-TB treatment

dc.contributor.authorNada Pitabuten_US
dc.contributor.authorPanadda Dhepaksonen_US
dc.contributor.authorShinsaku Sakuradaen_US
dc.contributor.authorNaoto Keichoen_US
dc.contributor.authorSrisin Khusmithen_US
dc.contributor.otherKing Mongkuts University of Technologyen_US
dc.contributor.otherNational Center for Global Health and Medicineen_US
dc.contributor.otherThailand Ministry of Public Healthen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherThe Research Institute of Tuberculosis, Japan Anti-Tuberculosis Associationen_US
dc.date.accessioned2020-10-05T04:00:13Z
dc.date.available2020-10-05T04:00:13Z
dc.date.issued2020-08-01en_US
dc.description.abstract© 2020 by the authors. Licensee MDPI, Basel, Switzerland. Granule-associated killing molecules released from cytotoxic T lymphocytes participate as a crucial step in immunity against tuberculosis (TB), but the role of coordinated production remains controversial. Coordinated release of effector molecules in vitro after stimulating peripheral blood mononuclear cells (PBMCs) of active TB or HIV/TB coinfection patients with PPD, purified protein derivative of tuberculin and avirulent Mtb, H37Ra, an attenuated strain were investigated in association with clinical outcomes. Perforin, granzyme-B, granulysin and IFN-γ were measured using ELISA. Before anti-TB treatment, PBMCs of TB stimulated with PPD or H37Ra released higher perforin, granzyme-B, and granulysin levels than in HIV/TB and released significantly higher IFN-γ (p = 0.045, p = 0.022). Granulysin positively correlated with perforin in TB (p = 0.042, r = 0.385), HIV/TB coinfection (p = 0.003, r = 0.941) after PPD stimulation, and after H37Ra stimulation in TB (p = 0.005, r = 0.549), but negatively correlated with granzyme B in TB (p = 0.042, r = −0.386), HIV/TB coinfection (p = 0.042, r = 0.754) were noted. After anti-TB treatment, increased levels of perforin, granulysin and IFN-γ in TB or HIV/TB upon PPD or H37Ra stimulation, and decreased granzyme-B levels after PPD (p = 0.003) or H37Ra (p = 0.028) stimulation in TB were observed. These results suggest that granulysin may act synergistic with perforin and IFN-γ in TB, indicating its crucial function in host immunity to tuberculosis. Future studies with larger numbers of patients ought to be conducted in the future.en_US
dc.identifier.citationPathogens. Vol.9, No.8 (2020), 1-12en_US
dc.identifier.doi10.3390/pathogens9080655en_US
dc.identifier.issn20760817en_US
dc.identifier.other2-s2.0-85089697974en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/58981
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85089697974&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titleCoordinated in vitro release of granulysin, perforin and IFN-γ in tb and HIV/TB co-infection associated with clinical outcomes before and after anti-TB treatmenten_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85089697974&origin=inwarden_US

Files

Collections